Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 909.00 GBp
Change Today -3.50 / -0.38%
Volume 23.9K
CSRT On Other Exchanges
Symbol
Exchange
OTC US
London
OTC US
London
London
As of 5:59 AM 06/30/15 All times are local (Market data is delayed by at least 15 minutes).

consort medical plc (CSRT) Snapshot

Open
910.00 GBp
Previous Close
912.50 GBp
Day High
910.50 GBp
Day Low
908.00 GBp
52 Week High
06/3/15 - 1,003 GBp
52 Week Low
10/21/14 - 650.00 GBp
Market Cap
446.1M
Average Volume 10 Days
126.6K
EPS TTM
0.23 GBp
Shares Outstanding
49.1M
EX-Date
09/24/15
P/E TM
39.4x
Dividend
20.12 GBp
Dividend Yield
2.21%
Current Stock Chart for CONSORT MEDICAL PLC (CSRT)

Related News

No related news articles were found.

consort medical plc (CSRT) Related Businessweek News

No Related Businessweek News Found

consort medical plc (CSRT) Details

Consort Medical plc designs, develops, manufactures, and sells specialty medical drug delivery devices and services to the pharmaceutical industry in Europe, the United States, and internationally. It offers metered dose inhaler valves, dry powder inhalers, integrated dose counters, actuators, disposable auto injectors, needle-free injectors, nasal drug delivery devices, nicotine inhalation devices, point of care diagnostics devices, and medical check valves, which are used to treat asthma and chronic obstructive pulmonary diseases. The company also manufactures anodized parts and pressings; and offers auto-injector platforms, syringe systems, video laryngoscopes, and narina nasal products, as well as provides commercial services. Consort Medical plc was incorporated in 1946 and is based in Hemel Hempstead, the United Kingdom.

Founded in 1946

consort medical plc (CSRT) Top Compensated Officers

Chief Executive Officer, Director, Member of ...
Total Annual Compensation: 834.0K GBP
Chief Financial Officer, Group Finance Direct...
Total Annual Compensation: 465.0K GBP
Compensation as of Fiscal Year 2014.

consort medical plc (CSRT) Key Developments

Consort Medical plc., 2015 Earnings Call, Jun 16, 2015

Consort Medical plc., 2015 Earnings Call, Jun 16, 2015

Consort Medical plc Proposes Final Dividend, Payable on 24 October 2015

Consort Medical plc announced that the Board is proposing an unchanged final dividend of 11.68 pence against 11.68 pence a year ago, making a total dividend for the year of 18.11 pence against 18.11 pence a year ago. It will be paid on 24 October 2015 to shareholders who are on the register on 19 September 2015.

Consort Medical plc announces Unaudited Consolidated Earnings Results for the Year Ended April 30, 2015

Consort Medical plc announced unaudited consolidated earnings results for the year ended April 30, 2015. For the year, the company reported revenue of GBP 184,825,000 against GBP 100,010,000 a year ago. Operating profit was GBP 8,164,000 against GBP 17,406,000 a year ago. Profit before tax was GBP 5,512,000 against GBP 16,140,000 a year ago. Profit for the financial year from continuing operations was GBP 6,262,000 against GBP 13,646,000 a year ago. Profit for the financial year from continuing operations before special items was 15.1 pence per diluted share against 40.5 pence per diluted share a year ago. Profit for the financial year was GBP 4,948,000 or 15.4 pence per basic share against GBP 12,968,000 or 41.5 pence per diluted share a year ago. Adjusted diluted earnings per ordinary share were 46.9 pence against 41.4 pence a year ago. Net cash inflow from operating activities was GBP 12,108,000 against GBP 13,771,000 a year ago. Purchases of property, plant and equipment were GBP 20,500,000 against GBP 16,134,000 a year ago. Purchases of intangible assets were GBP 178,000 against GBP 158,000 a year ago. Net debt came in just below GBP 100 million. EBITDA (before special items) was GBP 24.4 million against GBP 33.2 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CSRT:LN 909.00 GBp -3.50

CSRT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Carclo PLC 147.00 GBp -2.00
Gerresheimer AG €54.64 EUR +1.00
Rexam PLC 556.00 GBp -5.00
West Pharmaceutical Services Inc $57.89 USD -0.74
View Industry Companies
 

Industry Analysis

CSRT

Industry Average

Valuation CSRT Industry Range
Price/Earnings 62.1x
Price/Sales 2.7x
Price/Book 2.5x
Price/Cash Flow 93.2x
TEV/Sales 2.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CONSORT MEDICAL PLC, please visit www.consortmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.